Literature DB >> 9155592

Acute effect of low dose theophylline on the circulatory disturbances of cirrhosis.

E H Forrest1, I A Bouchier, P C Hayes.   

Abstract

BACKGROUND: Adenosine is a potent vasoactive substance that may be responsible for mediating the altered haemodynamics found in patients with cirrhosis. AIM: The administration of oral theophylline was used to investigate the effect of adenosine receptor antagonism upon the circulation of patients with cirrhosis.
METHODS: Twenty eight patients were given oral theophylline and intravascular haemodynamic measurements obtained over approximately one hour.
RESULTS: After 240 mg of oral theophylline elixir the hepatic venous pressure gradient mean fell from 21.8 (2.1) to 19.9 (2.4) mm Hg (p < 0.01), and azygos blood flow fell from 481 (94) to 375 (83) ml/min (p < 0.05). There were no changes in cardiac output or systemic vascular resistance despite a fall in mean arterial pressure (92.2 (2.0) to 89.2 (1.8) mm Hg; p < 0.05) and a rise in heart rate (78.3 (3.0) to 82.4 (3.2); p < 0.001). Left renal vein flow measured by a reverse thermodilution catheter rose from 387 (91) to 601 (119) ml/ min (p < 0.05). The proportion of cardiac output perfusing the left kidney rose from 5.0 (1.3) to 9.7 (2.8)%.
CONCLUSIONS: These changes indicate a significant role for adenosine in the renal vasoconstriction and a more minor role in the maintenance of portal hypertension.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155592      PMCID: PMC1027024          DOI: 10.1136/gut.40.1.139

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  35 in total

Review 1.  Nitric oxide: the elusive mediator of the hyperdynamic circulation of cirrhosis?

Authors:  B J Whittle; S Moncada
Journal:  Hepatology       Date:  1992-10       Impact factor: 17.425

Review 2.  Review article: the pathophysiology and pharmacological treatment of portal hypertension.

Authors:  R D Grose; P C Hayes
Journal:  Aliment Pharmacol Ther       Date:  1992-10       Impact factor: 8.171

3.  The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.

Authors:  J CAESAR; S SHALDON; L CHIANDUSSI; L GUEVARA; S SHERLOCK
Journal:  Clin Sci       Date:  1961-08       Impact factor: 6.124

4.  The effects of aminophylline and other xanthines on the pulmonary circulation.

Authors:  C W QUIMBY; D M AVIADO; C F SCHMIDT
Journal:  J Pharmacol Exp Ther       Date:  1958-03       Impact factor: 4.030

5.  [Some cases of simultaneous tricuspid and mitral surgery (stenosis and insufficiency)].

Authors:  P Michaud; H Termet; C Agé; J Chassignolle
Journal:  Ann Chir Thorac Cardiovasc       Date:  1968-04

6.  Caffeine and theophylline attenuate adenosine-induced vasodilation in humans.

Authors:  P Smits; J W Lenders; T Thien
Journal:  Clin Pharmacol Ther       Date:  1990-10       Impact factor: 6.875

7.  Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction.

Authors:  S H Um; O Nishida; M Tokubayashi; F Kimura; Y Takimoto; H Yoshioka; R Inque; T Kita
Journal:  Hepatology       Date:  1994-01       Impact factor: 17.425

8.  Adenosine modulation of hepatic arterial but not portal venous constriction induced by sympathetic nerves, norepinephrine, angiotensin, and vasopressin in the cat.

Authors:  W W Lautt; D J Legare
Journal:  Can J Physiol Pharmacol       Date:  1986-04       Impact factor: 2.273

9.  Pharmacokinetics of theophylline in hepatic disease.

Authors:  A Mangione; T E Imhoff; R V Lee; L Y Shum; W J Jusko
Journal:  Chest       Date:  1978-05       Impact factor: 9.410

10.  Effect of dipyridamole on kidney function in cirrhosis.

Authors:  J Llach; P Ginès; V Arroyo; J M Salmerón; A Ginès; W Jiménez; J Gaya; F Rivera; J Rodés
Journal:  Hepatology       Date:  1993-01       Impact factor: 17.425

View more
  2 in total

Review 1.  Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease.

Authors:  S Møller; J H Henriksen
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

2.  Vascular stasis, intestinal hemorrhage, and heightened vascular permeability complicate acute portal hypertension in cd39-null mice.

Authors:  Xiaofeng Sun; Andrés Cárdenas; Yan Wu; Keichi Enjyoji; Simon C Robson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-06-11       Impact factor: 4.052

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.